J&J Stock Hits Record Highs: Key Drivers and Growth Outlook
Johnson & Johnson shares finished at a record close above $275, extending their winning streak to seven straight sessions, according to market data. UBS analysts raised their price target on the healthcare giant to $320 per share from $280, pointing to an inflecting top-line growth rate and a shift toward higher-margin products. Jim agreed with … Read more
